No Data
No Data
No Data
No Data
No Data
INVO, EZGO and WISA Among Pre-market Losers
Seeking AlphaApr 18 08:15 ET
Significant reduction in liver fat! Organovo Holdings (ONVO.US) announces positive trial results for MASH therapy
Organovo Holdings (ONVO.US) announced the positive results of its phase 2 trial of the drug FXR314 for the treatment of patients with metabolic function-related steatohepatitis (MASH).
Zhitong FinanceApr 16 09:29 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersDynatronics (NASDAQ:DYNT) stock rose 84.9% to $0.69 during Tuesday's pre-market session. The company's market cap stands at $3.3 million. BioRestorative Therapies (NASDAQ:BRTX) shares rose 23.4
BenzingaApr 16 08:07 ET
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
BenzingaApr 15 14:11 ET
Why Organovo Stock Is Up Today
Organovo Holdings, Inc. (NASDAQ:ONVO) shares are trading higher Monday after the company announced Phase 2 results for FXR314. The Details:Organovo released the complete details of its 16-week, random
BenzingaApr 15 10:56 ET
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also
BenzingaApr 15 10:00 ET
Ismer Amizur : ONVO... what's ur target price.. haha
NASSER09OP Ismer Amizur: Not my but all analysis company see the target is 8.55$ so the best is in now to win later
Ismer Amizur NASSER09OP: what about INDO... can it rally to usd 80-90 once again?
No Data
No Data